{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:12:39Z","timestamp":1778004759370,"version":"3.51.4"},"reference-count":23,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.3892\/or.2013.2701","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T06:10:40Z","timestamp":1377583840000},"page":"2279-2287","source":"Crossref","is-referenced-by-count":14,"title":["Overexpression of heparanase in ovarian cancer and its clinical significance"],"prefix":"10.3892","volume":"30","author":[{"given":"WEI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONG","family":"CHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LOUWEI","family":"WEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHONGMIAN","family":"PAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIEQING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,8,27]]},"reference":[{"key":"key20180107223547_b1-or-30-05-2279","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/GRF.0b013e3181961625","article-title":"Ovarian cancer: detection and radiologic staging","volume":"52","author":"Shaaban","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"key20180107223547_b2-or-30-05-2279","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11670-011-0003-9","article-title":"Cancer incidence and mortality in China, 2006","volume":"23","author":"Chen","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"key20180107223547_b3-or-30-05-2279","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/10525","article-title":"Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis","volume":"5","author":"Hulett","year":"1999","journal-title":"Nat Med"},{"key":"key20180107223547_b4-or-30-05-2279","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-4899-2444-5_34","article-title":"Control of angiogenesis by heparin and other sulfated polysaccharides","volume":"313","author":"Folkman","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"key20180107223547_b5-or-30-05-2279","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)65669-6","article-title":"Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization","volume":"153","author":"Mesiano","year":"1998","journal-title":"Am J Pathol"},{"key":"key20180107223547_b6-or-30-05-2279","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbrc.2012.02.069","article-title":"Silencing glypican-3 expression induces apoptosis in human hepatocellular carcinoma cells","volume":"419","author":"Liu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107223547_b7-or-30-05-2279","doi-asserted-by":"crossref","first-page":"e31379","DOI":"10.1371\/journal.pone.0031379","article-title":"Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"key":"key20180107223547_b8-or-30-05-2279","doi-asserted-by":"crossref","first-page":"e31454","DOI":"10.1371\/journal.pone.0031454","article-title":"Interaction between mouse adenovirus type 1 and cell surface heparan sulfate proteoglycans","volume":"7","author":"Lenaerts","year":"2012","journal-title":"PLoS One"},{"key":"key20180107223547_b9-or-30-05-2279","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1369\/0022155411428469","article-title":"Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans","volume":"60","author":"Yoneda","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"key20180107223547_b10-or-30-05-2279","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1158\/1078-0432.CCR-03-0103","article-title":"Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer","volume":"10","author":"Davies","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107223547_b11-or-30-05-2279","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1074\/jbc.M304872200","article-title":"Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion","volume":"279","author":"Reiland","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107223547_b12-or-30-05-2279","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cncr.21648","article-title":"Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival","volume":"106","author":"Quiros","year":"2006","journal-title":"Cancer"},{"key":"key20180107223547_b13-or-30-05-2279","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/IGC.0b013e3181a834a2","article-title":"Heparanase-2 expression in normal ovarian epithelium and in benign and malignant ovarian tumors","volume":"19","author":"de Moura","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107223547_b14-or-30-05-2279","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MEG.0b013e3282fc2649","article-title":"Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma","volume":"20","author":"Peretti","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180107223547_b15-or-30-05-2279","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3748\/wjg.v16.i3.306","article-title":"Heparanase and hepatocellular carcinoma: promoter or inhibitor?","volume":"16","author":"Dong","year":"2010","journal-title":"World J Gastroenterol"},{"key":"key20180107223547_b16-or-30-05-2279","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2006.08.045","article-title":"Heparanase expression correlates with poor survival in metastatic ovarian carcinoma","volume":"104","author":"Davidson","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107223547_b17-or-30-05-2279","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/01443610802323542","article-title":"Heparanase expression in endometrial cancer: analysis of immunohistochemistry","volume":"28","author":"Inamine","year":"2008","journal-title":"J Obstet Gynaecol"},{"key":"key20180107223547_b18-or-30-05-2279","first-page":"1133","article-title":"Expression of heparanase, Mdm2, and erbB2 in ovarian cancer","volume":"18","author":"Ginath","year":"2001","journal-title":"Int J Oncol"},{"key":"key20180107223547_b19-or-30-05-2279","first-page":"3423","article-title":"Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis","volume":"31","author":"Zhang","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107223547_b20-or-30-05-2279","first-page":"7733","article-title":"Heparanase affects adhesive and tumorigenic potential of human glioma cells","volume":"63","author":"Zetser","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107223547_b21-or-30-05-2279","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/jnci\/djh230","article-title":"Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis","volume":"96","author":"Edovitsky","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key20180107223547_b22-or-30-05-2279","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2010.01190.x","article-title":"Pre-clinical and clinical significance of heparanase in Ewing's sarcoma","volume":"15","author":"Shafat","year":"2011","journal-title":"J Cell Mol Med"},{"key":"key20180107223547_b23-or-30-05-2279","first-page":"562","article-title":"Heparanase participates in the growth and invasion of human U-2OS osteosarcoma cells and its close relationship with hypoxia-inducible factor-1alpha in osteosarcoma","volume":"57","author":"Z","year":"2010","journal-title":"Neoplasma"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2701\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:45:25Z","timestamp":1515347125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,8,27]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.3892\/or.2013.2701"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2701","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,27]]}}}